Shanxi Zhendong Pharmaceutical Co.,Ltd

SZSE:300158 Stock Report

Market Cap: CN¥4.2b

Shanxi Zhendong PharmaceuticalLtd Past Earnings Performance

Past criteria checks 0/6

Shanxi Zhendong PharmaceuticalLtd has been growing earnings at an average annual rate of 17.2%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 2.8% per year.

Key information

17.2%

Earnings growth rate

17.2%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate-2.8%
Return on equity-0.5%
Net Margin-0.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Surges 31% Yet Its Low P/S Is No Reason For Excitement

Mar 07
Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Surges 31% Yet Its Low P/S Is No Reason For Excitement

Revenue & Expenses Breakdown

How Shanxi Zhendong PharmaceuticalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300158 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 243,457-201,638181
31 Dec 233,626-441,741191
30 Sep 233,709-911,780194
30 Jun 233,936-611,850177
31 Mar 233,791-611,825175
01 Jan 233,729-511,793178
30 Sep 223,8412,3191,935194
30 Jun 224,1732,4212,126222
31 Mar 224,6892,5292,415223
01 Jan 225,0942,6172,653219
30 Sep 215,5283782,782161
30 Jun 215,5203652,864151
31 Mar 215,1962992,740149
31 Dec 204,8482622,576136
30 Sep 204,6532082,594177
30 Jun 204,4011542,435172
31 Mar 204,4451522,482163
31 Dec 194,3991432,492145
30 Sep 194,155-672,430168
30 Jun 193,772-1332,305134
31 Mar 193,546-1472,132128
31 Dec 183,420-1472,078123
30 Sep 183,7461202,116122
30 Jun 183,7382331,956151
31 Mar 183,7862951,828131
31 Dec 173,7323021,632118
30 Sep 173,7023431,39844
30 Jun 173,7773301,3270
31 Mar 173,5042431,2600
31 Dec 163,2832031,1820
30 Sep 162,6881171,0370
30 Jun 162,383679330
31 Mar 162,323679080
31 Dec 152,262659200
30 Sep 152,165518090
30 Jun 152,199438320
31 Mar 152,010407940
31 Dec 141,919427650
30 Sep 141,673567600
30 Jun 141,711707250
31 Mar 141,695687030
31 Dec 131,658746950
30 Sep 131,630856890
30 Jun 131,457876970

Quality Earnings: 300158 is currently unprofitable.

Growing Profit Margin: 300158 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300158 is unprofitable, but has reduced losses over the past 5 years at a rate of 17.2% per year.

Accelerating Growth: Unable to compare 300158's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300158 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-0.8%).


Return on Equity

High ROE: 300158 has a negative Return on Equity (-0.48%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.